- Home
- / Shenzhen Kangtai Biological Products
Shenzhen Kangtai Biological Products
Stock Price
¥19.2
2024-10-29
Market Capitalization
¥20.7 B
2024-10-29
Revenue
¥2.6 B
FY, 2025
Shenzhen Kangtai Biological Products Summary
Company Summary
- Overview
- Shenzhen Kangtai Biological Products (深圳康泰生物制品股份有限公司) is a company that specializes in the research, development, production, and sales of human vaccines. It offers Haemophilus influenzae type b combined and recombinant hepatitis B vaccines, measles and rubella, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1992
- HQ
- Shenzhen, CN | view all locations
- Website
- https://www.biokangtai.com
- Cybersecurity rating
Table of Contents
LocationsView all
3 locations detected
Shenzhen HQ
China
Room 101, Kangtai Group Building, No. 222, Kefa Road, Science and Technology Park Community, Yuehai Street
Shenzhen, Guang Dong Sheng
China
No. 128, Songwang 1st Road, Xili Street
Shenzhen, Guang Dong Sheng
China
No. 18, Shutianpu Road, Martin Street
Shenzhen Kangtai Biological Products Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥624.2M
- Gross profit (Q1, 2026)
- ¥441.7M
- Net income (Q1, 2026)
- ¥33.6M
- Cash (Q1, 2026)
- ¥169.3M
- EBIT (Q1, 2026)
- ¥62.8M
- Enterprise value
- $22.5B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026